ES2121755T3 - Fraccion de caseina para uso terapeutico, profilactico y/o diagnostico en infecciones del tracto respiratorio. - Google Patents

Fraccion de caseina para uso terapeutico, profilactico y/o diagnostico en infecciones del tracto respiratorio.

Info

Publication number
ES2121755T3
ES2121755T3 ES90916537T ES90916537T ES2121755T3 ES 2121755 T3 ES2121755 T3 ES 2121755T3 ES 90916537 T ES90916537 T ES 90916537T ES 90916537 T ES90916537 T ES 90916537T ES 2121755 T3 ES2121755 T3 ES 2121755T3
Authority
ES
Spain
Prior art keywords
respiratory tract
therapeutic
prophyltic
caseine
fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90916537T
Other languages
English (en)
Inventor
Bengt Andersson
Gustaf Aniansson
Ragnar Lindstedt
Eden Catharina Svanborg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2121755T3 publication Critical patent/ES2121755T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202—Casein or caseinates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

LA INVENCION SE REFIERE AL USO DE CASEINA DERIVADA DE LA LECHE, PREFERIBLEMENTE DE LECHE HUMANA, Y LECHE PORCINA, PARA LA PREPARACION DE UN SUSTRATO PARA EL TRATAMIENTO PROFILACTICO Y/O TERAPEUTICO DE INFECCIONES DE LAS VIAS RESPIRATORIAS CON S.PNEUMONIAE Y/O H.INFLUENZAE, ASI COMO EN EL USO DE DIAGNOSTICO DE TALES COMPUESTOS PARA DIAGNOSTICAR INFECCIONES CAUSADAS POR DICHAS BACTERIAS.
ES90916537T 1989-10-30 1990-10-30 Fraccion de caseina para uso terapeutico, profilactico y/o diagnostico en infecciones del tracto respiratorio. Expired - Lifetime ES2121755T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8903625A SE465109B (sv) 1989-10-30 1989-10-30 Antibakteriell komposition

Publications (1)

Publication Number Publication Date
ES2121755T3 true ES2121755T3 (es) 1998-12-16

Family

ID=20377332

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90916537T Expired - Lifetime ES2121755T3 (es) 1989-10-30 1990-10-30 Fraccion de caseina para uso terapeutico, profilactico y/o diagnostico en infecciones del tracto respiratorio.

Country Status (15)

Country Link
EP (1) EP0454813B1 (es)
JP (1) JPH04503077A (es)
KR (1) KR920700678A (es)
AT (1) ATE170754T1 (es)
AU (1) AU633647B2 (es)
CA (1) CA2044244A1 (es)
DE (1) DE69032646T2 (es)
DK (1) DK0454813T3 (es)
ES (1) ES2121755T3 (es)
FI (1) FI102516B1 (es)
HU (1) HU212935B (es)
NO (1) NO912391D0 (es)
RU (1) RU2035913C1 (es)
SE (1) SE465109B (es)
WO (1) WO1991006308A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707968A (en) * 1994-05-26 1998-01-13 Abbott Laboratories Inhibition of attachment of H.influenzae to human cells
US5506209A (en) * 1994-05-26 1996-04-09 Abbott Laboratories Product for inhibition of infection of mammalian cells by respiratory syncytial virus
US5643880A (en) * 1994-05-26 1997-07-01 Abbott Laboratories Product for inhibition of attachment of H. influenzae to human cells
WO1995032727A1 (en) * 1994-05-26 1995-12-07 Abbott Laboratories Inhibition of infection of mammalian cells by respiratory syncytial virus
AU695101B2 (en) * 1994-05-26 1998-08-06 Abbott Laboratories Inhibition of attachment of (H. influenzae) to human cells
US5538952A (en) * 1994-05-26 1996-07-23 Abbott Laboratories Inhibition of infection of mammalian cells by respiratory syncytial virus
US5942254A (en) * 1995-02-27 1999-08-24 Abbott Laboratories Phosphorylated recombinant human β-casein expressed in a bacterial system
JP2000500141A (ja) * 1995-11-06 2000-01-11 アボツト・ラボラトリーズ リン酸化された組換えヒトベータ−カゼインを用いるヒト細胞に対するインフルエンザ菌の付着阻止方法
JP2000503319A (ja) * 1995-11-06 2000-03-21 アボツト・ラボラトリーズ インフルエンザ菌のヒト細胞への付着を防止するための生成物
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
US20060198817A1 (en) 2002-11-26 2006-09-07 Alverdy John C Materials and methods for preventing and treating microbe-mediated epithelial disorders
BRPI0814412A2 (pt) * 2007-07-06 2017-05-23 Laclede Inc uso de enzimas hidrolíticas e oxidativas para dissolver biofilme nas passagens das vias aéreas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496671A (en) * 1975-03-27 1977-12-30 Grindstedvaerket As Anti-cancer-active sour milk fraction
FR2491334A1 (fr) * 1980-10-03 1982-04-09 Inst Nat Sante Rech Med Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
FR2592769B1 (fr) * 1986-01-10 1990-10-12 Agronomique Inst Nat Rech Procede d'obtention d'une matiere enrichie en caseine beta, appareillage pour la mise en oeuvre de ce procede, et application des produits obtenus par ce procede comme aliments, complements alimentaires ou additifs en industrie alimentaire et pharmaceutique ou dans la preparation de peptides a activite physiologique
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤

Also Published As

Publication number Publication date
DE69032646D1 (de) 1998-10-15
FI102516B (fi) 1998-12-31
CA2044244A1 (en) 1991-05-01
JPH04503077A (ja) 1992-06-04
SE465109B (sv) 1991-07-29
FI913154A0 (fi) 1991-06-28
KR920700678A (ko) 1992-08-10
AU633647B2 (en) 1993-02-04
EP0454813A1 (en) 1991-11-06
AU6647090A (en) 1991-05-31
DE69032646T2 (de) 1999-05-27
RU2035913C1 (ru) 1995-05-27
FI102516B1 (fi) 1998-12-31
HU212935B (en) 1996-12-30
WO1991006308A1 (en) 1991-05-16
NO912391L (no) 1991-06-19
SE8903625D0 (sv) 1989-10-30
SE8903625L (sv) 1991-05-01
ATE170754T1 (de) 1998-09-15
DK0454813T3 (da) 1999-02-01
EP0454813B1 (en) 1998-09-09
NO912391D0 (no) 1991-06-19

Similar Documents

Publication Publication Date Title
EP0909814A3 (en) Use of protein kinases for the diagnosis and treatment of Alzheimer's disease
ES2121755T3 (es) Fraccion de caseina para uso terapeutico, profilactico y/o diagnostico en infecciones del tracto respiratorio.
EP2261358A3 (en) Novel streptococcus antigen
EP1757697A3 (en) Group B streptococcus antigens
ATE165395T1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
MXPA03000103A (es) Antigenos de streptococcus.
DE69636228D1 (de) Therapeutische Zusammensetzungen zur Behandlung von Lawsonia intracellularis Infektionen
EP1731166A3 (en) Streptococcus pneumoniae proteins and vaccines
DE59007518D1 (de) Sterilfiltrierte Kolostralmilch.
DE69100444D1 (de) Magermilchbehandlungsverfahren.
DK398683A (da) Fremgangsmaade til fremstilling af antistoffer
DE69002946T2 (de) Paracetamol enthaltende arzneizubereitung.
CA2197659C (en) Antibacterial composition containing multimeric alpha-lactalbumin
Majury et al. Preliminary investigation of the mechanism of inhibition of bovine lymphocyte proliferation by Pasteurella haemolytica A1 leukotoxin
ATE71299T1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
ATE27822T1 (de) Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus.
ITRM930055A0 (it) Composizione per l'alimentazione di soggetti, neonati ed adulti che non tollerano le proteine del latte vaccino e della soia e/o il lattosio.
EP1950302A3 (en) Streptococcus antigens
Kumar ISOLATION, PARTIAL CHARACTERIZATION, AND ANTIMICROBIAL ACTIVITY OF IMMUNOGLOBULIN-M FROM BOVINE COLOSTRUM AND MILK
EP1219635A3 (en) Chlamydia pneumoniae antigenes

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 454813

Country of ref document: ES